[1]
|
Kaiya H, Kangawa K, Miyazato M (2013) What is the general action of ghrelin for vertebrates? -comparisons of ghrelin's effects across vertebrates. Gen Comp Endocrinol 181: 187-191.
|
[2]
|
Braman SS (2006) The global burden of asthma. Chest 130: 4s-12s. doi: 10.1378/chest.130.1_suppl.4S
|
[3]
|
Croisant S (2014) Epidemiology of asthma: prevalence and burden of disease. Adv Exp Med Biol 795: 17-29. doi: 10.1007/978-1-4614-8603-9_2
|
[4]
|
Holgate ST (2011) Asthma: a simple concept but in reality a complex disease. Eur J Clin Invest 41: 1339-1352. doi: 10.1111/j.1365-2362.2011.02534.x
|
[5]
|
Webley WC, Hahn DL (2017) Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides. Respir Res 18: 98. doi: 10.1186/s12931-017-0584-z
|
[6]
|
Schuijs MJ, Willart MA, Hammad H, et al. (2013) Cytokine targets in airway inflammation. Curr Opin Pharmacol 13: 351-361. doi: 10.1016/j.coph.2013.03.013
|
[7]
|
Tliba O, Amrani Y, Panettieri RA, et al. (2008) Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? Chest 133: 236-242. doi: 10.1378/chest.07-0262
|
[8]
|
Singh SR, Sutcliffe A, Kaur D, et al. (2014) CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration. Allergy 69: 1189-1197. doi: 10.1111/all.12444
|
[9]
|
McKay S, Sharma HS (2002) Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir Res 3: 11.
|
[10]
|
Koziol-White CJ, Panettieri RA, et al. (2011) Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev 242: 178-185. doi: 10.1111/j.1600-065X.2011.01022.x
|
[11]
|
Ozier A, Allard B, Bara I, et al. (2011) The pivotal role of airway smooth muscle in asthma pathophysiology. J Allergy (Cairo) 2011: 742710.
|
[12]
|
Zheng Y, Tang L, Huang W, et al. (2015) Anti-Inflammatory Effects of Ang-(1–7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway. PLoS One 10: e0136187. doi: 10.1371/journal.pone.0136187
|
[13]
|
Padda RS, Shi Y, Lo CS, et al. (2015) Angiotensin-(1–7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes? J Diabetes Metab 6.
|
[14]
|
Ruiz-Ortega M, Esteban V, Ruperez M, et al. (2006) Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15: 159-166. doi: 10.1097/01.mnh.0000203190.34643.d4
|
[15]
|
Li C, He J, Zhong X, et al. (2018) CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Inflammatory Cytokine Production. Inflammation.
|
[16]
|
Li HY, Yang M, Li Z, et al. (2017) Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-gamma activity and reducing oxidative stress. Int J Mol Med 39: 1307-1316. doi: 10.3892/ijmm.2017.2924
|
[17]
|
Bihl JC, Zhang C, Zhao Y, et al. (2015) Angiotensin-(1–7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFsmall ka, CyrillicB inflammatory pathway. Vascul Pharmacol 73: 115-123. doi: 10.1016/j.vph.2015.08.007
|
[18]
|
Pang L, Nie M, Corbett L, et al. (2006) Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 176: 3788-3795. doi: 10.4049/jimmunol.176.6.3788
|
[19]
|
Sutcliffe AM, Clarke DL, Bradbury DA, et al. (2009) Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1. Br J Pharmacol 157: 436-450. doi: 10.1111/j.1476-5381.2009.00143.x
|
[20]
|
Deacon K, Knox AJ (2015) Human airway smooth muscle cells secrete amphiregulin via bradykinin/COX-2/PGE2, inducing COX-2, CXCL8, and VEGF expression in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 309: L237-249. doi: 10.1152/ajplung.00390.2014
|
[21]
|
Gangur V, Oppenheim JJ (2000) Are chemokines essential or secondary participants in allergic responses? Ann Allergy Asthma Immunol 84: 569-579. doi: 10.1016/S1081-1206(10)62403-9
|
[22]
|
Sousa AR, Lane SJ, Nakhosteen JA, et al. (1994) Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 10: 142-147. doi: 10.1165/ajrcmb.10.2.8110469
|
[23]
|
Watson ML, Grix SP, Jordan NJ, et al. (1998) Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine 10: 346-352. doi: 10.1006/cyto.1997.0350
|
[24]
|
Nie M, Corbett L, Knox AJ, et al. (2005) Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. J Biol Chem 280: 2550-2561. doi: 10.1074/jbc.M410616200
|
[25]
|
Wang YX, Ji ML, Jiang CY, et al. (2016) Upregulation of ICAM-1 and IL-1beta protein expression promotes lung injury in chronic obstructive pulmonary disease. Genet Mol Res 15.
|
[26]
|
Liang B, Wang X, Zhang N, et al. (2015) Angiotensin-(1–7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-kappaB Pathways in HUVECs. Cell Physiol Biochem 35: 2472-2482. doi: 10.1159/000374047
|